Deprenylation triggers the extrinsic apoptosis pathway by increasing DR5 expression, enhancing TRAIL-mediated apoptotic signaling, activating caspase- 3, and promoting tumor cell death [276]. This evidence concerns the gene CASP3 and neoplasm.